Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival

Elizabeth A. Beierle, Wei Dai, Radha Iyengar, Max Langham, Edward M. Copeland, Mike K. Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background/Purpose: Aggressive tumors may alter their expression of Bcl-2 proteins to decrease apoptosis and increase survival. The authors reported previously that neuroblastoma cells have diminished apoptosis when placed in coculture with hepatocytes to stimulate a metastatic environment. It was hypothesized that the expression of proapoptotic (Bax) and prosurvival (Bcl-2 and Mcl-1) proteins would be altered in neuroblastoma cells grown in a cell culture model of metastatic neuroblastoma. Methods: Human neuroblastoma cells (IMR-32) were grown alone or in coculture with human hepatocytes for 2, 3, or 4 days. Bcl-2, Mcl-1, and Bax mRNA were measured with reverse transcriptase polymerase chain reaction (RT-PCR). Results: Bcl-2, an antiapoptotic protein, was significantly increased in cocultured neuroblastoma cells by day 4. Bax, a proapoptotic protein, was significantly diminished by day 3. No significant change in Mcl-1 occurred in this study. Conclusions: When neuroblastoma cells placed in coculture, the prosurvival protein, Bcl-2, is upregulated whereas the proapoptotic protein, Bax, is downregulated. The combination of these changes can maximally enhance the survival rate of neuroblastoma cells in coculture. The propensity for neuroblastoma to either metastasize or regress may be associated with its ability to differentially regulate the expression of different members of the Bcl-2 protein family.

Original languageEnglish (US)
Pages (from-to)486-491
Number of pages6
JournalJournal of Pediatric Surgery
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Neuroblastoma
Survival
Coculture Techniques
Proteins
Hepatocytes
Apoptosis
bcl-2-Associated X Protein
Reverse Transcriptase Polymerase Chain Reaction
Down-Regulation
Cell Culture Techniques
Messenger RNA
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival. / Beierle, Elizabeth A.; Dai, Wei; Iyengar, Radha; Langham, Max; Copeland, Edward M.; Chen, Mike K.

In: Journal of Pediatric Surgery, Vol. 38, No. 3, 01.03.2003, p. 486-491.

Research output: Contribution to journalArticle

Beierle, Elizabeth A. ; Dai, Wei ; Iyengar, Radha ; Langham, Max ; Copeland, Edward M. ; Chen, Mike K. / Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival. In: Journal of Pediatric Surgery. 2003 ; Vol. 38, No. 3. pp. 486-491.
@article{c872823b53ee4b038dd7ab64be7b0f49,
title = "Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival",
abstract = "Background/Purpose: Aggressive tumors may alter their expression of Bcl-2 proteins to decrease apoptosis and increase survival. The authors reported previously that neuroblastoma cells have diminished apoptosis when placed in coculture with hepatocytes to stimulate a metastatic environment. It was hypothesized that the expression of proapoptotic (Bax) and prosurvival (Bcl-2 and Mcl-1) proteins would be altered in neuroblastoma cells grown in a cell culture model of metastatic neuroblastoma. Methods: Human neuroblastoma cells (IMR-32) were grown alone or in coculture with human hepatocytes for 2, 3, or 4 days. Bcl-2, Mcl-1, and Bax mRNA were measured with reverse transcriptase polymerase chain reaction (RT-PCR). Results: Bcl-2, an antiapoptotic protein, was significantly increased in cocultured neuroblastoma cells by day 4. Bax, a proapoptotic protein, was significantly diminished by day 3. No significant change in Mcl-1 occurred in this study. Conclusions: When neuroblastoma cells placed in coculture, the prosurvival protein, Bcl-2, is upregulated whereas the proapoptotic protein, Bax, is downregulated. The combination of these changes can maximally enhance the survival rate of neuroblastoma cells in coculture. The propensity for neuroblastoma to either metastasize or regress may be associated with its ability to differentially regulate the expression of different members of the Bcl-2 protein family.",
author = "Beierle, {Elizabeth A.} and Wei Dai and Radha Iyengar and Max Langham and Copeland, {Edward M.} and Chen, {Mike K.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1053/jpsu.2003.50085",
language = "English (US)",
volume = "38",
pages = "486--491",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival

AU - Beierle, Elizabeth A.

AU - Dai, Wei

AU - Iyengar, Radha

AU - Langham, Max

AU - Copeland, Edward M.

AU - Chen, Mike K.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Background/Purpose: Aggressive tumors may alter their expression of Bcl-2 proteins to decrease apoptosis and increase survival. The authors reported previously that neuroblastoma cells have diminished apoptosis when placed in coculture with hepatocytes to stimulate a metastatic environment. It was hypothesized that the expression of proapoptotic (Bax) and prosurvival (Bcl-2 and Mcl-1) proteins would be altered in neuroblastoma cells grown in a cell culture model of metastatic neuroblastoma. Methods: Human neuroblastoma cells (IMR-32) were grown alone or in coculture with human hepatocytes for 2, 3, or 4 days. Bcl-2, Mcl-1, and Bax mRNA were measured with reverse transcriptase polymerase chain reaction (RT-PCR). Results: Bcl-2, an antiapoptotic protein, was significantly increased in cocultured neuroblastoma cells by day 4. Bax, a proapoptotic protein, was significantly diminished by day 3. No significant change in Mcl-1 occurred in this study. Conclusions: When neuroblastoma cells placed in coculture, the prosurvival protein, Bcl-2, is upregulated whereas the proapoptotic protein, Bax, is downregulated. The combination of these changes can maximally enhance the survival rate of neuroblastoma cells in coculture. The propensity for neuroblastoma to either metastasize or regress may be associated with its ability to differentially regulate the expression of different members of the Bcl-2 protein family.

AB - Background/Purpose: Aggressive tumors may alter their expression of Bcl-2 proteins to decrease apoptosis and increase survival. The authors reported previously that neuroblastoma cells have diminished apoptosis when placed in coculture with hepatocytes to stimulate a metastatic environment. It was hypothesized that the expression of proapoptotic (Bax) and prosurvival (Bcl-2 and Mcl-1) proteins would be altered in neuroblastoma cells grown in a cell culture model of metastatic neuroblastoma. Methods: Human neuroblastoma cells (IMR-32) were grown alone or in coculture with human hepatocytes for 2, 3, or 4 days. Bcl-2, Mcl-1, and Bax mRNA were measured with reverse transcriptase polymerase chain reaction (RT-PCR). Results: Bcl-2, an antiapoptotic protein, was significantly increased in cocultured neuroblastoma cells by day 4. Bax, a proapoptotic protein, was significantly diminished by day 3. No significant change in Mcl-1 occurred in this study. Conclusions: When neuroblastoma cells placed in coculture, the prosurvival protein, Bcl-2, is upregulated whereas the proapoptotic protein, Bax, is downregulated. The combination of these changes can maximally enhance the survival rate of neuroblastoma cells in coculture. The propensity for neuroblastoma to either metastasize or regress may be associated with its ability to differentially regulate the expression of different members of the Bcl-2 protein family.

UR - http://www.scopus.com/inward/record.url?scp=0037371922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037371922&partnerID=8YFLogxK

U2 - 10.1053/jpsu.2003.50085

DO - 10.1053/jpsu.2003.50085

M3 - Article

C2 - 12632373

AN - SCOPUS:0037371922

VL - 38

SP - 486

EP - 491

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 3

ER -